Clinical Trial Update: A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma [Phase 3]

View source ↗

Summary

This update reports the results from a Phase 3 study evaluating the efficacy and safety of tralokinumab in adults and adolescents with uncontrolled asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Tralokinumab (tralokinumab)

Snippet

Sponsor: AstraZeneca | Conditions: Uncontrolled Asthma | Phase 3 | Status: COMPLETED | Results posted: 2018-03-21